Clinical Trials Browser

OTHER × Sarcoma, Ewing × regorafenib × Clear all

Pathologic Complete Response, Bone Neoplasms, Chondrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Patient Compliance, Sarcoma, Ewing, Osteosarcoma, Histiocytoma, Malignant Fibrous

NCT05830084 2026-01-06

REGO-INTER-EWI

Phase 1 Active not recruiting

23 enrolled

Sarcoma

Sarcoma, Ewing

Clinical Trials

REGOSTA

REGO-INTER-EWI